Application 211852
- Type
- ANDA
- Sponsor
- CIPLA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | DEFERASIROX | DEFERASIROX | TABLET;ORAL | 90MG | No | No |
| 002 | DEFERASIROX | DEFERASIROX | TABLET;ORAL | 360MG | No | No |
| 003 | DEFERASIROX | DEFERASIROX | TABLET;ORAL | 180MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A211852-001 | DEFERASIROX | DEFERASIROX | 90MG | TABLET / ORAL | 2020-02-11 | ||
| A211852-002 | DEFERASIROX | DEFERASIROX | 360MG | TABLET / ORAL | 2020-02-11 | ||
| A211852-003 | DEFERASIROX | DEFERASIROX | 180MG | TABLET / ORAL | 2020-06-15 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A211852-001 | DEFERASIROX | 90MG | TABLET / ORAL | 2020-02-11 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | A211852-002 | DEFERASIROX | 360MG | TABLET / ORAL | 2020-02-11 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | A211852-003 | DEFERASIROX | 180MG | TABLET / ORAL | 2020-06-15 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A211852-001 | DEFERASIROX | 90MG | TABLET / ORAL | 2020-02-11 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A211852-002 | DEFERASIROX | 360MG | TABLET / ORAL | 2020-02-11 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A211852-003 | DEFERASIROX | 180MG | TABLET / ORAL | 2020-06-15 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A211852-001 | DEFERASIROX | 90MG | TABLET / ORAL | 2020-02-11 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A211852-002 | DEFERASIROX | 360MG | TABLET / ORAL | 2020-02-11 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A211852-003 | DEFERASIROX | 180MG | TABLET / ORAL | 2020-06-15 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A211852-001 | DEFERASIROX | 90MG | TABLET / ORAL | 2020-02-11 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A211852-002 | DEFERASIROX | 360MG | TABLET / ORAL | 2020-02-11 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A211852-003 | DEFERASIROX | 180MG | TABLET / ORAL | 2020-06-15 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A211852-001 | DEFERASIROX | 90MG | TABLET / ORAL | 2020-02-11 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A211852-002 | DEFERASIROX | 360MG | TABLET / ORAL | 2020-02-11 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A211852-003 | DEFERASIROX | 180MG | TABLET / ORAL | 2020-06-15 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A211852-001 | DEFERASIROX | 90MG | TABLET / ORAL | 2020-02-11 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A211852-002 | DEFERASIROX | 360MG | TABLET / ORAL | 2020-02-11 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A211852-003 | DEFERASIROX | 180MG | TABLET / ORAL | 2020-06-15 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A211852-001 | DEFERASIROX | 90MG | TABLET / ORAL | 2020-02-11 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A211852-002 | DEFERASIROX | 360MG | TABLET / ORAL | 2020-02-11 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A211852-003 | DEFERASIROX | 180MG | TABLET / ORAL | 2020-06-15 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A211852-001 | DEFERASIROX | 90MG | TABLET / ORAL | 2020-02-11 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A211852-002 | DEFERASIROX | 360MG | TABLET / ORAL | 2020-02-11 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A211852-003 | DEFERASIROX | 180MG | TABLET / ORAL | 2020-06-15 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A211852-001 | DEFERASIROX | 90MG | TABLET / ORAL | 2020-02-11 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A211852-002 | DEFERASIROX | 360MG | TABLET / ORAL | 2020-02-11 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A211852-003 | DEFERASIROX | 180MG | TABLET / ORAL | 2020-06-15 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A211852-001 | DEFERASIROX | 90MG | TABLET / ORAL | 2020-02-11 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A211852-002 | DEFERASIROX | 360MG | TABLET / ORAL | 2020-02-11 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A211852-003 | DEFERASIROX | 180MG | TABLET / ORAL | 2020-06-15 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A211852-001 | DEFERASIROX | 90MG | TABLET / ORAL | 2020-02-11 | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A211852-002 | DEFERASIROX | 360MG | TABLET / ORAL | 2020-02-11 | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A211852-003 | DEFERASIROX | 180MG | TABLET / ORAL | 2020-06-15 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A211852-001 | DEFERASIROX | 90MG | TABLET / ORAL | 2020-02-11 | d06236e962d9… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A211852-002 | DEFERASIROX | 360MG | TABLET / ORAL | 2020-02-11 | d06236e962d9… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A211852-003 | DEFERASIROX | 180MG | TABLET / ORAL | 2020-06-15 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A211852-001 | DEFERASIROX | 90MG | TABLET / ORAL | 2020-02-11 | 79d66fd596c7… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A211852-002 | DEFERASIROX | 360MG | TABLET / ORAL | 2020-02-11 | 79d66fd596c7… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A211852-003 | DEFERASIROX | 180MG | TABLET / ORAL | 2020-06-15 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A211852-001 | DEFERASIROX | 90MG | TABLET / ORAL | 2020-02-11 | 301d65b070ca… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A211852-001 | AB | 1 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A211852-002 | AB | 1 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A211852-003 | AB | 1 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | A211852-001 | AB | 1 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | A211852-002 | AB | 1 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | A211852-003 | AB | 1 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | A211852-001 | AB | 1 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | A211852-002 | AB | 1 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | A211852-003 | AB | 1 | 4b0b4de00fa7… |
| 2022-03-09 01:35 UTC | 2022-03 | A211852-001 | AB | 1 | bb7c543d1eb4… |
| 2022-03-09 01:35 UTC | 2022-03 | A211852-002 | AB | 1 | bb7c543d1eb4… |
| 2022-03-09 01:35 UTC | 2022-03 | A211852-003 | AB | 1 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | A211852-001 | AB | 1 | 782e0a99824c… |
| 2021-12-28 21:50 UTC | 2021-12 | A211852-002 | AB | 1 | 782e0a99824c… |
| 2021-12-28 21:50 UTC | 2021-12 | A211852-003 | AB | 1 | 782e0a99824c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A211852-001 | AB | 1 | 87673890dc5c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A211852-002 | AB | 1 | 87673890dc5c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A211852-003 | AB | 1 | 87673890dc5c… |
| 2021-03-12 10:30 UTC | 2021-03 | A211852-001 | AB | 1 | 5aa47cf7b7d7… |
| 2021-03-12 10:30 UTC | 2021-03 | A211852-002 | AB | 1 | 5aa47cf7b7d7… |
| 2021-03-12 10:30 UTC | 2021-03 | A211852-003 | AB | 1 | 5aa47cf7b7d7… |
| 2020-12-22 03:56 UTC | 2020-12 | A211852-001 | AB | 1 | 8869cabd3fbd… |
| 2020-12-22 03:56 UTC | 2020-12 | A211852-002 | AB | 1 | 8869cabd3fbd… |
| 2020-12-22 03:56 UTC | 2020-12 | A211852-003 | AB | 1 | 8869cabd3fbd… |
| 2020-11-12 02:37 UTC | 2020-11 | A211852-001 | AB | 1 | c0c555d07b60… |
| 2020-11-12 02:37 UTC | 2020-11 | A211852-002 | AB | 1 | c0c555d07b60… |
| 2020-11-12 02:37 UTC | 2020-11 | A211852-003 | AB | 1 | c0c555d07b60… |
| 2023-01-26 05:58 UTC | 2023-01 | A211852-001 | AB | 1 | 3bdfa0b2c4d7… |
| 2023-01-26 05:58 UTC | 2023-01 | A211852-002 | AB | 1 | 3bdfa0b2c4d7… |
| 2023-01-26 05:58 UTC | 2023-01 | A211852-003 | AB | 1 | 3bdfa0b2c4d7… |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A211852-001 | AB | 1 | 3a93d1ddd44b… |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A211852-002 | AB | 1 | 3a93d1ddd44b… |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A211852-003 | AB | 1 | 3a93d1ddd44b… |
| 2022-10-28 04:53 UTC | 2022-10 | A211852-001 | AB | 1 | f41ea6bd6efb… |
| 2022-10-28 04:53 UTC | 2022-10 | A211852-002 | AB | 1 | f41ea6bd6efb… |
| 2022-10-28 04:53 UTC | 2022-10 | A211852-003 | AB | 1 | f41ea6bd6efb… |
| 2022-09-29 23:25 UTC | 2022-09 | A211852-001 | AB | 1 | e64feba35796… |
| 2022-09-29 23:25 UTC | 2022-09 | A211852-002 | AB | 1 | e64feba35796… |
| 2022-09-29 23:25 UTC | 2022-09 | A211852-003 | AB | 1 | e64feba35796… |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A211852-001 | AB | 1 | cb3db0bc1861… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| deferasirox | DEFERASIROX | Zydus Pharmaceuticals USA Inc. | 4af5bc9e-3e09-4dfd-8cc8-7677953c9c7c | 2023-07-24 | Boxed warning, Warnings, Adverse reactions | deferasirox DEFERASIROX |
| Deferasirox | DEFERASIROX | Alembic Pharmaceuticals Inc. | 1f9f1a69-bf71-4e6a-88b0-90f08c4da79f | 2023-03-16 | Boxed warning, Warnings, Adverse reactions | Deferasirox DEFERASIROX |
| DEFERASIROX | DEFERASIROX | Alembic Pharmaceuticals Inc. | f1f952c8-89f5-4a2f-bd6b-9b384366d971 | 2023-02-28 | Boxed warning, Warnings, Adverse reactions | DEFERASIROX DEFERASIROX |
| Deferasirox | DEFERASIROX | Alembic Pharmaceuticals Limited | 8c8b84f3-6887-4485-b5e0-03f254b88a15 | 2023-01-30 | Boxed warning, Warnings, Adverse reactions | Deferasirox DEFERASIROX |
| DEFERASIROX | DEFERASIROX | Alembic Pharmaceuticals Limited | dd9450f4-7c95-4322-8806-9820570f5aa2 | 2023-01-30 | Boxed warning, Warnings, Adverse reactions | DEFERASIROX DEFERASIROX |
| Deferasorox | DEFERASIROX | Novadoz Pharmaceuticals LLC | 1122f1c0-c160-49db-a31b-90d7521370f5 | 2022-05-20 | Boxed warning, Warnings, Adverse reactions | DEFERASIROX |
| Deferasirox | DEFERASIROX | Cipla USA Inc. | 31c5a91f-e901-418b-a519-779a0c245477 | 2021-07-08 | Boxed warning, Warnings, Adverse reactions | Deferasirox DEFERASIROX |
| Deferasirox | DEFERASIROX | MSN LABORATORIES PRIVATE LIMITED | 0354cbc7-9b32-4513-976a-2ef2da39b6b3 | 2021-01-08 | Boxed warning, Warnings, Adverse reactions | Deferasirox DEFERASIROX |
| Deferasirox | DEFERASIROX | Dr. Reddy's Laboratories Inc | e365e748-4b61-94f2-fb7a-f81919eaccaa | 2020-12-30 | Boxed warning, Warnings, Adverse reactions | Deferasirox DEFERASIROX |
| Deferasirox | DEFERASIROX | MSN LABORATORIES PRIVATE LIMITED | e0726c9c-cee8-4fc1-abd1-68ad0db030dd | 2020-12-22 | Boxed warning, Warnings, Adverse reactions | Deferasirox DEFERASIROX |
| Deferasirox | DEFERASIROX | Amneal Pharmaceuticals NY LLC | a7ae9c31-e14f-4cf9-9ab3-850519f1a87c | 2020-10-29 | Boxed warning, Warnings, Adverse reactions | Deferasirox DEFERASIROX |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 69097-391 | deferasirox | deferasirox | Cipla USA Inc. | ANDA | Current |
| 69097-391 | deferasirox | deferasirox | Cipla USA Inc. | ANDA | Current |
| 69097-391 | deferasirox | deferasirox | Cipla USA Inc. | ANDA | Current |
| 69097-391 | deferasirox | deferasirox | Cipla USA Inc. | ANDA | Current |
| 69097-391 | deferasirox | deferasirox | Cipla USA Inc. | ANDA | Current |
| 69097-392 | deferasirox | deferasirox | Cipla USA Inc. | ANDA | Current |
| 69097-392 | deferasirox | deferasirox | Cipla USA Inc. | ANDA | Current |
| 69097-392 | deferasirox | deferasirox | Cipla USA Inc. | ANDA | Current |
| 69097-392 | deferasirox | deferasirox | Cipla USA Inc. | ANDA | Current |
| 69097-393 | deferasirox | deferasirox | Cipla USA Inc. | ANDA | Current |
| 69097-393 | deferasirox | deferasirox | Cipla USA Inc. | ANDA | Current |
| 69097-393 | deferasirox | deferasirox | Cipla USA Inc. | ANDA | Current |
| 69097-393 | deferasirox | deferasirox | Cipla USA Inc. | ANDA | Current |
| 69097-393 | deferasirox | deferasirox | Cipla USA Inc. | ANDA | Current |